skip to main content
Primo Search
Search in: Busca Geral
Tipo de recurso Mostra resultados com: Mostra resultados com: Índice

Is travel health a new destination for pharmacy practice and business? An examination of revenue opportunities from pre-travel consultations

Houle, Sherilyn

Canadian pharmacists journal, 2018-11, Vol.151 (6), p.383-387 [Periódico revisado por pares]

Los Angeles, CA: SAGE Publications

Texto completo disponível

Citações Citado por
  • Título:
    Is travel health a new destination for pharmacy practice and business? An examination of revenue opportunities from pre-travel consultations
  • Autor: Houle, Sherilyn
  • Assuntos: Drug stores ; Fees & charges ; Immunization ; Prescription drugs ; Research and Clinical
  • É parte de: Canadian pharmacists journal, 2018-11, Vol.151 (6), p.383-387
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: Whereas an exhaustive review of the literature is outside the scope of this paper, an overview of the evidence and potential roles for pharmacists has been published.2 Pharmacist involvement in travel health, often studied in the context of a pharmacist-performed pre-travel consultation with recommendations communicated to a prescriber, has resulted in strong adherence by patients to recommended therapies,3,4 high patient satisfaction3-5 and more cost-effective care than consultations performed by nurses, as a result of less use of unnecessary vaccinations and medications.5 A recently published study of pharmacist-performed pre-travel consultations in Alberta provides further evidence of patient adherence and satisfaction. While vaccine administration fees at this clinic are included as part of the consultation fee, a survey of community pharmacists in Ontario found that the average fee charged for administration of travel vaccines in that province is $20 per injection, so this value will be applied in this analysis.8 Additionally, 2 reports of pharmacy dispensing fees in Ontario and British Columbia were used to determine an average overall fee of $9.62, which will be assumed for this paper.9-10 Results Among the 103 patients enrolled, the average age was 36 years and 46% (n = 47) were male. Table 1 Summary of recommendations Recommendation type All destinations (n = 103) Mexico/Caribbean only (n = 27) Total injections (including total duration of vaccination series for multiple-dose regimens) 3.18 (1.97) 2.74 (1.53) Prescription drugs – Available in brand only (Malarone) 0.32 (0.47) 0.11 (0.31) Prescription drugs – Available as generic (acetazolamide, azithromycin, ciprofloxacin, chloroquine, dexamethasone, doxycycline, mefloquine) 1.16 (0.46) 1.04 (0.33) Nonprescription drug products (bismuth subsalicylate, dimenhydrinate, Dukoral, scopolamine patch) 2.05 (0.43) 1.96 (0.44) Other nonprescription products (insect repellent, oral rehydration solution/powder, sunscreen) 2.71 (0.55) 2.81 (0.47) Data are the mean (SD) per patient. Conclusion Future research and knowledge translation efforts will focus on identifying and addressing barriers related to providing this service and developing practice tools and guidance documents to support pharmacists in providing travel health advice and care, and identifying when a referral to a specialized travel health care provider is warranted.
  • Editor: Los Angeles, CA: SAGE Publications
  • Idioma: Inglês;Francês

Buscando em bases de dados remotas. Favor aguardar.